Literature DB >> 28736965

Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors.

Ryan P Goepfert1, C David Fuller2, G Brandon Gunn2, Ehab Y Hanna1, Jan S Lewin1, Jhankruti S Zaveri1, Rachel M Hubbard1, Martha P Barrow1, Katherine A Hutcheson1.   

Abstract

BACKGROUND: The purpose of this study was to characterize decisional regret and its association with symptom burden in a large cohort of oropharyngeal carcinoma (OPC) survivors.
METHODS: A cross-sectional survey was administered to 1729 OPC survivors. Survey items included a multisymptom inventory and a validated decisional regret inventory. Associations between regret and symptom scores were analyzed to determine and rank symptom drivers of decisional regret.
RESULTS: Nine hundred seventy-two patients responded reporting a low level of decisional regret overall, although 15.5% communicated "moderate to strong" regret. Overall symptom score and treatment group were statistically significant predictors of decisional regret. Relative to other symptoms, difficulty swallowing and feeling sad were the strongest drivers of decisional regret.
CONCLUSION: OPC survivors provide a robust description of their long-term outcomes with 15.5% expressing "moderate to high" regret that was significantly associated with late symptom burden and multimodality treatment. Difficulty swallowing was the strongest driver of decisional regret.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  decisional regret; dysphagia; oropharyngeal carcinoma; survivorship; symptom

Mesh:

Year:  2017        PMID: 28736965     DOI: 10.1002/hed.24879

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

1.  Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis.

Authors:  Katherine A Hutcheson; Zhannat Nurgalieva; Hui Zhao; Gary B Gunn; Sharon H Giordano; Mihir K Bhayani; Jan S Lewin; Carol M Lewis
Journal:  Head Neck       Date:  2018-12-07       Impact factor: 3.147

2.  Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors.

Authors:  Puja Aggarwal; Jhankruti S Zaveri; Ryan P Goepfert; Qiuling Shi; Xianglin L Du; Michael Swartz; G Brandon Gunn; Stephen Y Lai; C David Fuller; Ehab Y Hanna; David I Rosenthal; Jan S Lewin; Linda B Piller; Katherine A Hutcheson
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-11-01       Impact factor: 6.223

3.  Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis.

Authors:  Puja Aggarwal; Jhankruti S Zaveri; Ryan P Goepfert; Qiuling Shi; Xianglin L Du; Michael Swartz; Stephen Y Lai; C David Fuller; Jan S Lewin; Linda B Piller; Katherine A Hutcheson
Journal:  Head Neck       Date:  2019-08-23       Impact factor: 3.147

4.  18F-FDG Metabolic Tumor Volume: Association with Short- and Long-Term Feeding Tube Use in Head and Neck IMRT.

Authors:  James E Jackson; Nigel J Anderson; Maureen Rolfo; Morikatsu Wada; Michal Schneider; Michael Poulsen; Maziar Fahandej; Anna Huynh; Sze Ting Lee; Daryl Lim Joon; Vincent Khoo
Journal:  Dysphagia       Date:  2018-09-28       Impact factor: 3.438

5.  Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting.

Authors:  V C Sandulache; Y L Lei; L E Heasley; M Chang; C I Amos; E M Sturgis; E Graboyes; E Y Chiao; N Rogus-Pulia; J Lewis; A Madabhushi; M J Frederick; A Sabichi; M Ittmann; W G Yarbrough; C H Chung; R Ferrarotto; Weiyuan Mai; H D Skinner; U Duvvuri; P Gerngross; A G Sikora
Journal:  Oral Oncol       Date:  2019-10-22       Impact factor: 5.337

6.  Perceived importance of affective forecasting in cancer treatment decision making.

Authors:  Laura M Perry; Michael Hoerger; Brittany D Korotkin; Paul R Duberstein
Journal:  J Psychosoc Oncol       Date:  2020-06-26

7.  Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial.

Authors:  G Brandon Gunn; Tito R Mendoza; Adam S Garden; Xin Shelley Wang; Qiuling Shi; William H Morrison; Steven J Frank; Jack Phan; Clifton D Fuller; Mark S Chambers; Ehab Y Hanna; Charles Lu; David I Rosenthal; Charles S Cleeland
Journal:  Support Care Cancer       Date:  2019-04-29       Impact factor: 3.603

8.  Untreated head and neck cancer: Natural history and associated factors.

Authors:  Paul Zolkind; Jake J Lee; Ryan S Jackson; Patrik Pipkorn; Sean T Massa
Journal:  Head Neck       Date:  2020-09-11       Impact factor: 3.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.